Fever and neutropenia.
Conditions
Interventions
Intervention group: Routine treatment group for fever and neutropenia (ceftazidime and amikacin) + vitamin D oral drops with a dose of 1000 units daily for two weeks.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 16 Years
Inclusion criteria
Inclusion criteria: pediatric hematology and oncology department of Amirkabir Arak Hospital, aged 1 to 16 years, with fever and neutropenia due to chemotherapy, informed consent of the patient's parents for the child to participate in the study, the initial vitamin D level is lower than the normal level) by the initial vitamin D level test D is measured and values ??less than 20 ng/ml are considered as deficiency and values ??of 29 ng/ml are considered as insufficient.) Not taking vitamins arbitrarily
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever and neutropenia. Timepoint: For each patient on the 3rd, 7th, 10th, 14th day, the results are recorded as full treatment, partial treatment or no treatment. Method of measurement: The level of neutropenia is checked by the CBC test, which is routinely taken every other day from hospitalized patients, and The degree of fever is also recorded by the ward nurse with a thermometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsara atoufi najaf abadi
Arak University of Medical Sciences
Outcome results
None listed